Coordinating Better Outcomes in Multiple Myeloma
Co-Chairs, R. Donald Harvey, PharmD, BCOP, FCCP, FHOPA, and Zahra Mahmoudjafari, PharmD, MBA, BCOP, discuss multiple myeloma in this CPE activity titled “Coordinating Better Outcomes in Multiple Myeloma: Pharmacist Leadership With Novel Antibodies and CAR-T Therapy.” For the full presentation, downloadable Practice Aids, slides, and complete CPE information, and to apply for credit, please visit us at PeerView.com/NDY865. CPE credit will be available until May 13, 2024.
Coordinating Better Outcomes in Multiple Myeloma
Теги
Zahra Mahmoudjafari PharmD MBA BCOPR Donald Harvey PharmD BCOP FCCP FHOPACMECPEmededoncologyhematologymultiple myelomaCAR-TpharmacistsCD38BCMAdaratumumabisatuximabide-celcilta-celteclistamabNDMMRRMMASCTTCRcellular therapyCD38 antibodiestripletsquadrupletsdosing considerationssafetyhypersensitivitypremedicationBCMA antibodiesbispecific antibodiesCRSneurotoxicityBCMA CAR-Tmultidisciplinary care teamICANScase forumAEs
